Louis Stokes Alliances for Minority Participation (LSAMP)

LSAMP Day. Pandemic to Endemic. April 21, 2021

LSAMP Day Pandemic to Endemic will be hosted on WebEx:
Meeting number: 2329 977 6306
Password: khGP3uPJ5v4
Join by video system: Dial 23299776306@bhcc.webex.com You can also dial and enter your meeting number.
Join by phone: 1-650-479-3208 Call-in toll number (US/Canada) Access code: 232 997 76306

Join LSAMP in a discussion on Pandemic to Endemic. Offered in partnership with UMass Boston, the LSAMP grant at BHCC supports opportunities for internships and career development for minority students majoring in STEM.

Download the event flyer.


1-1:05 p.m. Welcome
Suman Mukherjee, Ph.D., LSAMP Coordinator
Laura C. Rubin, Ph.D., Dean, Science, Engineering, and Mathematics

1:05-1:15 p.m. Introduction: Origin and Cause of a Pandemic
Suman Mukherjee, Ph.D., LSAMP Coordinator

1:15-1:25 p.m. Opportunity in Biology and Chemistry
Robert L. Steeper, Professor and Chair, Biology and Chemistry Department

1:25-1:30 p.m. REFLECTS Scholarship Program
JoDe M. Lavine, Ph.D., Assistant Dean, Science, Engineering, and Mathematics

1:30-1:40 p.m. STEM Internship Opportunity
Katharine V. Colello, Learn and Earn Coordinator

1:40-1:45 p.m. Massachusetts General Postdoc Association (MGPA) Mentor Program
Rose De Guzman, Ph.D., Neuroscientist/ National Science Research Associate (NSRA) Postdoctoral Fellow, Massachusetts General Hospital/Harvard Medical School

1:45-2:15 p.m. Guest Speaker: Ebenezer Tumban, Ph.D.
Pandemic to Endemic
Associate Professor of Molecular Virology and Vaccinology, School of Veterinary Medicine, Texas Technological University

2:15-2:30 p.m. Q&A and Open Discussion with Dr. Tumban


Ebenezer Tumban, Ph.D.
Associate Professor of Molecular Virology and Vaccinology, School of Veterinary Medicine, Texas Technological University

Tumban is a molecular virologist and vaccinologist by training. Before joining Texas Technological University, Dr. Tumban was an Associate Professor and the Graduate Program Director of the Department of Biological Sciences at Michigan Technological University (MTU), where he was one of the lead investigators who set up a COVID-19 testing laboratory on campus during the SARS-CoV-2 pandemic. He also prepared and supplied viral transport medium to hospitals/clinics for COVID-19 testing in the Upper Peninsula in Michigan.

Tumban’s research projects range from assessing the molecular determinants of arboviruses (such as dengue and Langat viruses) modes of transmission, the generation of recombinant antigens for developing immunodiagnostic kits against infectious agents (e.g. dengue viruses), to the development of candidate vaccines against viral infectious agents. Dr. Tumban is also a co-inventor on a U.S./European Union patent for a virus-like particle (VLP)-based L2 candidate vaccine against human papillomaviruses, which is licensed to Agilvax Biotech. He is currently interested in developing and testing candidate VLP-based subunit vaccines against viral infectious agents.

Tumban is an ad hoc reviewer for many scientific journals (including the Journal of Vaccine and the Journal of Antiviral Research) and he has served on grant review panels for the Department of Defense (U.S. Army Medical Research and Materiel Command's Office of Congressionally Directed Medical Research Grants). 

He enjoys educating students on infectious agents (viruses, bacteria, fungi), the biology of cancer, and the body's response to infectious agents.